Update on immunopathogenesis and immunotherapy in multiple sclerosis

@inproceedings{Selter2013UpdateOI,
  title={Update on immunopathogenesis and immunotherapy in multiple sclerosis},
  author={Rebecca C Selter and Bernhard Hemmer},
  booktitle={ImmunoTargets and therapy},
  year={2013}
}
Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Both genetic and environmental factors are believed to contribute to the pathogenesis of the disease. Histopathological findings suggest that multiple sclerosis is an immune-mediated disease, involving both the cellular and humoral immune systems. Within the last 20 years, several disease-modifying therapies for the treatment of multiple sclerosis were established. Moreover, promising new… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 90 references

IFN-beta induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis

M Chen, G Chen, +3 authors J. Hong
J Neuroimmunol • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…